China · 
What does BioTrack Capital invest in?
BioTrack Capital invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Biotechnology and Real Time.
BioTrack Capital highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series A and Series B: 100% of its rounds
What they do
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- BiotechnologyReal Time
- Based in
- Shanghai, China
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first3 appearances
- 2026
1 round
- Apr
- 2021
1 round
- Nov
- 2019
1 round
- Sept
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
PCPenghui ChenDirectoriForm ADV
ZZZhongji ZhiDirector of General PartneriFiling they signed
We also hold 6 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$62Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Biotrack Fund II GP Limited
- SEC number
- CRD 319337